This study is in progress, not accepting new patients
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
Summary
- Eligibility
- for people ages 20 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Kyoto Drug Discovery and Development Co., Ltd.
- ID
- NCT06178055
- Phase
- Phase 2 Central Retinal Artery Occlusion Research Study
- Study Type
- Interventional
- Participants
- Expecting 75 study participants
- Last Updated